Isabelle C. Van Gelder obtained her MD and PhD in Groningen, the where she also completed her cardiology and electrophysiology. Since 1995 she is working as cardiologist at the University Medical Center Groningen. Since 2006 she is Professor of Cardiology at the University of Groningen.
She is Board Member of EHRA and Chair of the EHRA Programme Committee 2020-2022. She is a visiting professor of the University of Southern Denmark, Odense, Denmark.
She was awarded with a Post Doc Netherlands Heart Foundation grant in 1994, an Interuniversity Cardiology Institute Netherlands post doc grant in 1995, and the Bert Talen Medal in 2016 by the Netherlands Heart Rhythm Association. She gave the European Society of Cardiology 2019 René Laënnec lecture on clinical cardiology and received the European Society of Cardiology silver medal for her work in clinical Cardiology.
She is a Fellow of the European Society of Cardiology and a Fellow of the European Heart Rhythm Association. She received > €20 million research grants for atrial fibrillation research, published >300 peer reviewed papers, and is a promotor of > 20 PhD students. She is PI of >30 trials including the RACE trials, STEEER-AF and EHRA- PATHs and steering committee member of >25 international trials including EAST, AXAFA, ASSERT, APAF-CRT, and RASTA-AF.
She was Task Force member of the ESC AF 2020 guidelines and is Associate Editor of the Europace and Heart. Her research focuses on understanding the susceptibility to atrial fibrillation and its adverse outcomes. It explores novel management strategies to prevent adverse outcomes with a focus on cardiovascular risk management and diagnosis and prevention of heart failure.
